Is a controlled trial of long-term oral anticoagulants in patients with stroke and non-rheumatic atrial fibrillation worthwhile?
A controlled randomised trial large enough to assess the value of anticoagulating stroke patients in atrial fibrillation would be difficult to conduct in the UK and the results would be applicable to only a small proportion of stroke patients. It would be more worthwhile to organise a trial that als...
Auteurs principaux: | Sandercock, P, Warlow, C, Bamford, J, Peto, R, Starkey, I |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
1986
|
Documents similaires
-
A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation
par: Andrei Viktorovich Fonyakin, et autres
Publié: (2012-09-01) -
Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
par: Paula Tiili, et autres
Publié: (2021-01-01) -
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
par: Tommaso Sacquegna, et autres
Publié: (2015-12-01) -
Prevalence of oral anticoagulation in atrial fibrillation
par: Eduardo Bartholomay, et autres
Publié: (2014-09-01) -
Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
par: Jin-Yi Hsu, et autres
Publié: (2022-07-01)